NexGel (NXGL) Competitors $2.32 +0.10 (+4.50%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.36 +0.04 (+1.68%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. APYX, VANI, BDMD, NTRB, INO, TELA, CTSO, LUNG, QTI, and SPAIShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Apyx Medical (APYX), Vivani Medical (VANI), Baird Medical Investment (BDMD), Nutriband (NTRB), Inovio Pharmaceuticals (INO), TELA Bio (TELA), Cytosorbents (CTSO), Pulmonx (LUNG), QT Imaging (QTI), and Safe Pro Group (SPAI). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Apyx Medical Vivani Medical Baird Medical Investment Nutriband Inovio Pharmaceuticals TELA Bio Cytosorbents Pulmonx QT Imaging Safe Pro Group NexGel (NASDAQ:NXGL) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk. Which has more risk & volatility, NXGL or APYX? NexGel has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Which has better earnings & valuation, NXGL or APYX? NexGel has higher earnings, but lower revenue than Apyx Medical. NexGel is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexGel$8.69M2.15-$3.28M-$0.40-5.80Apyx Medical$48.10M1.64-$23.46M-$0.45-4.64 Do institutionals and insiders have more ownership in NXGL or APYX? 2.2% of NexGel shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 20.6% of NexGel shares are owned by company insiders. Comparatively, 15.2% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media refer more to NXGL or APYX? In the previous week, Apyx Medical's average media sentiment score of 0.37 beat NexGel's score of -0.55 indicating that Apyx Medical is being referred to more favorably in the news media. Company Overall Sentiment NexGel Negative Apyx Medical Neutral Do analysts prefer NXGL or APYX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Is NXGL or APYX more profitable? NexGel has a net margin of -25.02% compared to Apyx Medical's net margin of -37.11%. NexGel's return on equity of -49.37% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets NexGel-25.02% -49.37% -25.68% Apyx Medical -37.11%-158.22%-28.30% SummaryNexGel and Apyx Medical tied by winning 7 of the 14 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.72M$7.05B$5.81B$9.76BDividend YieldN/A1.21%4.39%4.06%P/E Ratio-5.8027.4531.3626.05Price / Sales2.1569.66387.8788.42Price / CashN/A21.9338.0259.36Price / Book3.686.889.536.60Net Income-$3.28M$176.42M$3.26B$265.65M7 Day Performance-4.53%1.45%2.14%2.00%1 Month Performance-2.52%-1.85%3.22%0.46%1 Year Performance-10.77%9.53%30.18%18.88% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel1.1009 of 5 stars$2.32+4.5%N/A-10.8%$18.72M$8.69M-5.8010APYXApyx Medical1.6269 of 5 stars$1.96-8.4%N/A+59.5%$74.17M$48.10M-4.36270Gap UpVANIVivani Medical2.3873 of 5 stars$1.25+0.8%$4.00+220.0%-8.8%$74.05MN/A-2.7820News CoverageBDMDBaird Medical InvestmentN/A$2.04-4.2%N/AN/A$72.89MN/A0.00N/ANTRBNutriband3.5117 of 5 stars$6.33-0.5%$13.00+105.3%+18.9%$70.80M$2.14M-7.0610News CoverageShort Interest ↓INOInovio Pharmaceuticals4.1976 of 5 stars$1.91+0.3%$8.80+361.9%-73.9%$69.86M$220K-0.73320TELATELA Bio2.9863 of 5 stars$1.76+3.6%$4.50+155.5%-40.2%$69.77M$69.30M-1.57120CTSOCytosorbents2.0791 of 5 stars$1.08-1.8%$5.50+409.3%-15.5%$67.78M$35.60M-6.35220Analyst ForecastGap UpLUNGPulmonx3.9275 of 5 stars$1.55-3.4%$7.66+396.1%-77.5%$62.88M$83.79M-1.08250QTIQT ImagingN/A$2.12+4.4%N/A+218.0%$57.52M$4.00M0.00N/AGap UpSPAISafe Pro Group0.9225 of 5 stars$3.79-6.8%$8.00+111.4%N/A$57.42M$2.17M-4.7311News Coverage Related Companies and Tools Related Companies APYX Alternatives VANI Alternatives BDMD Alternatives NTRB Alternatives INO Alternatives TELA Alternatives CTSO Alternatives LUNG Alternatives QTI Alternatives SPAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access